Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of synthetic method of antibiotic cephalosporin nuclei

A synthesis method and technology for antibiotics are applied in the synthesis field of antibiotic cephalosporins, can solve problems such as low yield, high cost of raw materials, can not meet market demands, etc., achieve high product yield, improve solubility, reduce production costs and The effect of labor intensity

Active Publication Date: 2016-08-17
APELOA PHARM CO LTD +1
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0023] The existing AVNA synthesis process has the disadvantages of high raw material cost and low yield. With the continuous changes of the market, the existing process cost can no longer meet the market demand

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of synthetic method of antibiotic cephalosporin nuclei
  • A kind of synthetic method of antibiotic cephalosporin nuclei
  • A kind of synthetic method of antibiotic cephalosporin nuclei

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0048] (1) Preparation of reaction solution I: Weigh 53.4g GCLH in a 500ml three-necked flask (with thermometer, mechanical stirring), add 200ml acetonitrile, then add 28.8g triphenylphosphine, 11.3g sodium bromide, and then add 30% hydrochloric acid 1.1 g, heat up to 35°C, keep the temperature for 2 hours, and control the GCLH in the reaction solution to <1% by HPLC to obtain the reaction solution I, which contains compound 1;

[0049] (2) Preparation of reaction solution II: Cool the reaction solution I to zero, add 40% formaldehyde, then add (0.03mol) potassium carbonate / sodium hydroxide (0.08mol) mixed solution, and react at 5°C for 3 hours , HPLC control compound 1<0.5%, obtain reaction solution II, containing compound 2 in reaction solution II;

[0050] (3) Preparation of compound GVNA: Distill the reaction solution II under reduced pressure, control the temperature at 45° C., recover acetonitrile, precipitate a white solid, filter, put the obtained filter cake into 300 ...

Embodiment 2

[0053] (1) Preparation of reaction solution I: Weigh 50.2g GCLH in a 500ml three-neck flask (with thermometer, mechanical stirring), add 200ml acetone, then add 28.5g triphenylphosphine, 10.9g sodium bromide, and then add 40% hydrogen 1.1 g of bromic acid, heated up to 38° C., kept the temperature for 2.5 hours, and controlled GCLH<1% in the reaction solution by HPLC to obtain reaction solution I, which contained compound 1;

[0054] (2) Cool the reaction solution I to zero, add 40% formaldehyde, and then add (0.03mol) potassium carbonate / sodium hydroxide (0.08mol) mixed solution, control the temperature at 8°C for 2.5 hours, HPLC control compound 1< 0.5%, to obtain reaction solution II, which contains compound 2;

[0055] (3) Preparation of compound GVNA: The reaction solution II was distilled under reduced pressure, and the temperature was controlled at 47°C. After recovering acetone, a white solid was precipitated, filtered, and the obtained filter cake was put into 400ml o...

Embodiment 3

[0058] (1) Preparation of reaction solution I: Weigh 51.2g GCLH in a 500ml three-neck flask (with thermometer, mechanical stirring), add 200ml acetone, then add 28.3g triphenylphosphine, 11.1g sodium bromide, and then add 35% nitric acid 1.1 g, heat up to 40°C, keep the temperature for 3 hours, and control the GCLH in the reaction solution to <1% by HPLC to obtain the reaction solution I, which contains compound 1;

[0059] (2) Preparation of reaction solution II: cool the reaction solution I to zero, add 40% formaldehyde, then add (0.03mol) potassium carbonate / sodium hydroxide (0.08mol) mixed solution, and control the temperature at 10°C for 2 hours , HPLC control compound 1<0.5%, obtain reaction solution II, containing compound 2 in reaction solution II;

[0060] (3) Preparation of compound GVNA: The reaction solution II was distilled under reduced pressure, and the temperature was controlled at 50° C. After recovering acetone, a white solid was precipitated, filtered, and t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of synthesis of cephalosporin intermediates and in particular relates to a synthesis method of antibiotic cephalosporin mother nucleus. The synthesis method of the antibiotic cephalosporin mother nucleus comprises the following steps: (1) preparing a reaction liquid I; (2) preparing a reaction liquid II; (3) preparing a compound GVNA; and (4) preparing AVNA. The synthesis method of the antibiotic cephalosporin mother nucleus has the advantages that production cost is low, reaction time is short, recovery rate of the organic solvent is high, secondary utilization is facilitated, and product yield is high.

Description

technical field [0001] The invention belongs to the technical field of synthesis of cephalosporin intermediates, in particular to a method for synthesizing antibiotic cephalosporin nuclei. Background technique [0002] Both cefdinir and cefixime are third-generation cephalosporins. Cefdinir is mainly used in the treatment of acute exacerbation of chronic bronchitis, bacterial pneumonia, upper respiratory tract infection, skin and soft tissue infection. Cefixime in vitro against Streptococcus pneumoniae, Bacillus parainfluenzae, Proteus vulgaris, Klebsiella pneumoniae, Pasteurella multocida, Providencia, Salmonella, Shigella, Serratia marcescens , heteromorphic citric acid bacteria, and malonate citric acid bacteria also have antibacterial activity. It has the characteristics of broad-spectrum, high efficiency, enzyme resistance, and low toxicity. [0003] Both cefdinir and cefixime are anti-infective oral drugs widely used clinically, and the key nucleus for their synthesis...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D501/04C07D501/18
CPCC07D501/04C07D501/18
Inventor 厉昆孟杰吴中文魏伟葛政亮任红阳周国营
Owner APELOA PHARM CO LTD